Fair Value Calculator Fair Value Calculator
EN DE

CRSTCHM (CRSTCHM) Fair Value & Analysis

IN · Market cap ₹382M

C CRSTCHM CRSTCHM · BSE
Price₹127.25
Fair Value₹153.77
Upside+20.8%
Quality55/100
Watch CRSTCHM for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹95.84 – ₹339.65

Fair value as of: Jul 5, 2026

From 25 valuation models · updated today

Share price −5.6% over the past month.

Price vs Fair Value (12 months)

₹172.48 ₹77.77 Fair Value ₹153.77 Jul 2025 Jul 2026

12‑month range ₹77.77 – ₹172.48 · fair‑value band ₹95.84 – ₹339.65 · the ₹127.25 price screens below the ₹153.77 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CRSTCHM (CRSTCHM) currently trades at ₹127.25, while our model-based Fair Value estimate is ₹153.77 — implying the stock looks roughly 20.8% undervalued today. We read business quality at 55/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, CRSTCHM generated revenue of ₹266M at a net margin of 8.4%. Revenue grew 41.4% year over year. It earns a return on equity of 28.1%. Net debt stands at ₹2.6M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹95.84 (bear case) to ₹339.65 (bull case); at ₹127.25, the current price sits within that range. The share trades about 28% below its 52-week high and 74% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹266M
Revenue growth (YoY) +41.4%
Net margin 8.4%
Return on equity 28.1%
Free cash flow ₹14.1M FY2025
P/E ratio 14.1
More key figures
Operating margin 13.5%
EPS (TTM) ₹9.03
EPS growth (YoY) +80.8%
Net debt ₹2.6M FY2022

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

CRSTCHM reported revenue of ₹296M in FY2026 versus ₹79.5M in FY2022, a compound +38.9%/yr. Reported net income was ₹27.1M in FY2026, compounding +47.9%/yr from FY2022.

Revenue +38.9%/yr
FY22 ₹79.5M
FY23 ₹166M
FY24 ₹212M
FY25 ₹250M
FY26 ₹296M
Net income +47.9%/yr
FY22 ₹5.7M
FY23 ₹6.9M
FY24 ₹21.5M
FY25 ₹27.3M
FY26 ₹27.1M

Is CRSTCHM fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "CRSTCHM Fair Value". https://www.fairvalue-calculator.com/stock/CRSTCHM

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CRSTCHM (CRSTCHM) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹153.77 versus a price of ₹127.25 — about +21% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CRSTCHM?
Our model-based fair value for CRSTCHM is ₹153.77 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹127.25.
What is the quality score of CRSTCHM?
CRSTCHM has a Quality Score of 55/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of CRSTCHM (CRSTCHM)?
CRSTCHM reported trailing-twelve-month revenue of about ₹266M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of CRSTCHM?
The net profit margin of CRSTCHM is about 8.4%, meaning it keeps roughly 8.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.